Archive - Microcap Opportunities

Video Interview: Horizon Aircraft (Nasdaq: HOVR) with CEO Brandon Robinson

Hi Microcap Opportunities subscribers.

Aug 18 •

34:31

NeurAxis: Treating Virtually No One Within Its Addressable Market Is About To Change

NeurAxis - Our flagship position

Aug 17 •

Portfolio Change

We Are Dropping Delcath (DCTH)

Aug 13 •

NeurAxis is Looking Like a Slam Dunk

NeurAxis: From Bullish to Flagship Position

Aug 13 •

Portfolio Change

Dropping Cardiol Therapeutics (CRDL)

Aug 13 •

Ascent Forecast to A New Price High

We added Ascent Industries (ACNT) to our portfolio on April 26.

Aug 10 •

Portfolio Changes

My investment thesis in Connect Biopharma (CNTB) was recently presented here, and I disclosed that I have a position in this stock.

Aug 8 •

Connect Biopharma is Exploiting a Previously Hidden Asset

Connect Biopharma (CNTB) is a clinical-stage biopharmaceutical company for the treatment of inflammatory diseases.

Aug 5 •

July Performance Drives Portfolio to Impressive 43% Annual Gains

In the month of July our substack portfolio continues to thrive.

Aug 4 •

July 2025

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts